416375002: Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing tobramycin (medicinal product)\Product containing tobramycin in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by disposition (product)\Product containing tobramycin (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by disposition (product)\Product containing tobramycin (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Medicinal product categorized by structure\Product containing steroid (product)\Product containing androstane (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing steroid (product)\Product containing androstane (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing steroid (product)\Product containing androstane (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing loteprednol (medicinal product)\Product containing loteprednol in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Product containing tobramycin (medicinal product)\Product containing tobramycin in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Product containing tobramycin (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Product containing tobramycin (medicinal product)\Product containing loteprednol and tobramycin (medicinal product)\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Product manufactured as ocular dose form (product)\Product containing tobramycin in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Product manufactured as ocular dose form (product)\Product containing loteprednol in ocular dose form (medicinal product form)\Product containing loteprednol and tobramycin in ocular dose form (medicinal product form)\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3762275019 Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3762276018 Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Loteprednol etabonate + tobramycin	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Corticosterone	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Adrenal hormone agent	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Tobramycin (substance)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Loteprednol etabonate (substance)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Glucocorticoid hormone	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Bactericide	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has manufactured dose form	Ocular dose form (dose form)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Loteprednol etabonate ophthalmic preparation	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Product containing tobramycin in ophthalmic dosage form	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has manufactured dose form	Eye suspension	true	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Product containing loteprednol and tobramycin (medicinal product)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Product containing loteprednol in ocular dose form (medicinal product form)	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	TEMPORARY parent for CDs that are not updated	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	This attribute specifies the denominator unit for the concentration strength of a product.	mL	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	This attribute specifies the numerator unit for the concentration strength of a product.	mg	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Count of base of active ingredient	deux	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	This attribute specifies the denominator unit for the concentration strength of a product.	mL	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	This attribute specifies the numerator unit for the concentration strength of a product.	mg	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength denominator value	un	false	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength denominator value	un	false	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Loteprednol and tobramycin only product in ocular dose form	true	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Loteprednol etabonate (substance)	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Tobramycin (substance)	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Tobramycin (substance)	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength numerator value	cinq	false	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength numerator value	trois	false	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Loteprednol etabonate (substance)	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Plays role	Antibacterial therapeutic role (role)	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3762275019	Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3762276018	Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core